Critical Analysis and Quality Assessment of Nanomedicines and Nanocarriers in Clinical Trials: Three Years of Activity at the Clinical Trials Office

Investigational medicinal products submitted over the course of 3 years and authorized at the Clinical Trials Office of the Italian Medicines Agency as part of a request for authorization of clinical trials were scrutinized to identify those encompassing nanomedicines. The quality assessment reports...

Full description

Bibliographic Details

Main Authors:	Diego Alejandro Dri, Elisa Gaucci, Ilaria Torrieri, Maria Carafa, Carlotta Marianecci, Donatella Gramaglia
Format:	Artigo
Language:	Inglês
Published:	MDPI AG 2022-07-01
Series:	Pharmaceutics
Subjects:	clinical trials investigational medicinal products nanocarrier nanomedicine quality regulatory
Online Access:	https://www.mdpi.com/1999-4923/14/7/1438
Tags:	Add Tag No Tags, Be the first to tag this record!